Simplify Logo

Full-Time

Senior Manager

Forecasting and Analytics

Posted on 6/27/2024

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Hardware
Biotechnology

Senior, Expert

Somerset County, NJ, USA

Category
Strategy Development
Business & Strategy
Required Skills
Market Research
Sales
Communications
Branding/Brand Strategy
Data Analysis
Requirements
  • Minimum of a BS degree is required. MBA preferred.
  • Must have more than 3 years of experience in pharmaceutical forecasting. Must be proficient using Rx and other secondary audits, and epidemiology databases to develop forecasts as evidence by more than 3 years of work experience.
  • Must have more than 5 years of experience in use of forecasting and model building software. Must be proficient in identifying, applying and adapting analogs, benchmarks and order of entry models as evidenced by 5 years of work experience.
  • Minimum 5 years of experience working on analytical projects. Must have in depth understanding of the pharmaceutical supply chain, including manufacturers, wholesalers, and payers.
  • Must have more than 3 years’ experience in the application and use of analytical principles, methodologies, and statistics (statistical significance testing/confidence intervals, sampling) and multivariate statistics (regression analysis, cluster analysis, conjoint), probabilities and forecasting.
  • Must have excellent oral and written communication skills as evidenced by 5 years of experience.
Responsibilities
  • Develop in conjunction with appropriate alliance counterparts for our inline asset CARVYKTI, by leading the forecasts that address the impact of critical events, are logically designed, and well documented, and represent consensus decision making among key internal and external stakeholders.
  • Facilitate consensus-building among senior leaders to establish clear, visible, and rigorous sales expectations for the inline/pipeline assets by gaining their alignment and endorsement for forecast assumptions.
  • Help leadership identify actionable strategies to improve Commercial potential by identifying and prioritizing relevant risks & opportunities.
  • Analyze competitors and market dynamics to inform forecasting models and strategic decisions.
  • Develop an objective point of view of brand strategy by integrating insights across multiple functions and capability areas.
  • Leverage communication and people skills to influence leadership on recommended course of action.
  • Quantify uncertainty using scenario planning and advanced simulation models (e.g. Monte Carlo analysis, statistical trending).
  • Apply an in-depth understanding of diverse pharmaceutical data sources (e.g., Claims, Epidemiology, primary and secondary market research data sources etc.) and their nuances to develop and implement enhanced forecasting approaches and methodologies.
  • Develop an objective point of view of brand strategy by integrating insights across multiple functions and capability areas.
  • Guides the design of required market research studies to validate forecast assumptions, architecture, and patient populations in a given disease area.
  • Well versed with predictive forecasting methodologies for short term planning.
  • Ensure continued forecast visibility and organizational alignment through continued interactions and reporting with internal functions (ex. Commercial, Finance, and Supply Chain).
  • Provide recommendations on whether to go ahead with product development or discontinue certain projects based on market conditions, financial projections, and strategic goals.

Legend Biotech develops and sells cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's own cells to combat cancer. Unlike many competitors, Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments. Their goal is to provide effective treatments for hard-to-treat diseases through innovative cell therapy solutions.

Company Stage

IPO

Total Funding

$750.5M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

17%

1 year growth

38%

2 year growth

95%
Simplify Jobs

Simplify's Take

What believers are saying

  • Legend Biotech's recent European Commission approval for CARVYKTI® positions it as a leader in the multiple myeloma treatment market.
  • Strategic partnerships, such as the one with MaxCyte, enhance Legend Biotech's capabilities in cell engineering and expand its technological reach.
  • The company's commitment to transparency and investor relations, demonstrated through regular financial updates, fosters investor confidence and long-term stability.

What critics are saying

  • The competitive landscape in cell therapy and personalized medicine is intense, requiring continuous innovation to maintain market position.
  • Regulatory hurdles and the need for extensive clinical trials can delay the commercialization of new therapies, impacting revenue streams.

What makes Legend Biotech unique

  • Legend Biotech's technology-agnostic approach allows it to explore multiple innovative therapies, unlike competitors who may focus on a single technology.
  • The company's comprehensive business model, from discovery to commercialization, ensures control over the entire treatment lifecycle, providing a competitive edge.
  • Legend Biotech's strong focus on CAR-T therapies, particularly for hematological malignancies and solid tumors, sets it apart in the personalized medicine sector.
INACTIVE